AI Dit
Latest round
- Angel
Last raised
- May 2021
Total raised
- Undisclosed
Investors
- 1
About AI Dit
Based in Hangzhou, China and established in 2021, AI Dit is a biomedical Company that focuses on gene editing therapy. Dr. Lijia Ma, founder of the company, was responsible for a number of large-scale genomics research projects at BGI. The company engages in the research and development of gene editing therapy based on AI. It also engages in building a core R&D platform for CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) therapy.
Who invested in AI Dit
1 investor across 1 round
See all investors in AI Dit
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
May 11, 2021
Amount
Undisclosed
Investors
Questions about AI Dit
Who invested in AI Dit?
AI Dit has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AI Dit raised?
AI Dit has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did AI Dit last raise money?
AI Dit's most recent round on record is a Angel, in May 2021.
What does AI Dit do?
Based in Hangzhou, China and established in 2021, AI Dit is a biomedical Company that focuses on gene editing therapy.
Where is AI Dit headquartered?
AI Dit is headquartered in Hangzhou, China.
Which VCs invest in companies like AI Dit?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at AI Dit's stage. Their profiles are linked below.
VCs backing biotechnology startups at Angel
Raising like AI Dit? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.